91012-19-0

Usage

Uses

Used in Pharmaceutical Industry:
Methyl 3-(4-aminophenyl)propanoate is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to be incorporated into the molecular structures of drugs, enhancing their therapeutic properties and effectiveness.
Used in Agrochemical Industry:
Methyl 3-(4-aminophenyl)propanoate is utilized as a precursor in the production of agrochemicals, contributing to the development of pesticides and other agricultural chemicals that improve crop protection and yield.
Used in Organic Synthesis:
Methyl 3-(4-aminophenyl)propanoate serves as a versatile intermediate in organic synthesis, allowing for the creation of a variety of organic compounds for different applications across various industries. Its unique structure facilitates the formation of new chemical entities with potential uses in materials science, fine chemicals, and specialty chemicals.

InChI:InChI=1/C10H13NO2/c1-13-10(12)7-4-8-2-5-9(11)6-3-8/h2-3,5-6H,4,7,11H2,1H3

Upstream product

• 2393-17-1 3-(4-aminophenyl)propionic acid 
• 67-56-1 methanol 

Downstream Products

• 144656-26-8 Methyl 3-[4-[(2-hydroxy-propyl)-amino]-phenyl]-propionate 

Relevant academic research and scientific papers

Investigating Bicyclobutane-Triazolinedione Cycloadditions as a Tool for Peptide Modification

Acyl bicyclobutanes are shown to engage in strain-promoted cycloaddition reactions with a diverse array of triazolinedione reagents. The synthesis of an orthogonally protected urazole building block enabled the facile preparation of amino acid- and peptid

Piperazine derivatives, medicaments comprising these compounds, their use and processes for their preparation

The present invention relates to piperazine derivatives of the general formula STR1 in which Ra, Y1 to Y3 and E are defined herein, tautomers thereof, stereoisomers thereof, including their mixtures, and salts thereof, and in particular physiologically tolerated salts thereof with inorganic or organic acids or bases. These compounds have valuable pharmacological properties, such as aggregation-inhibiting activity. This invention also relates to medicaments comprising these compounds and to processes for the preparation of these compounds.

Piperazine derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them

Piperazine derivatives useful in the treatment or prevention of inflammation, bone degradation, thrombosis and tumor metastasis. Exemplary species are: (a) ?4-trans-?3-?4-(4-Pyridyl)-piperazin-1-yl!propionyl!amino!-cyclohexanecarboxylic acid, (b) 3-?4-trans-?4-(4-Pyridyl)-piperazin-1-yl!carbonylamino!-cyclohexylpropionic acid, (c) 3-?4-trans-?4-(4-Pyridyl)-piperazin-1-yl!malonylamino!cyclohexylcarboxylic acid, (d) Methyl ?4-trans-?3-?4-(4-pyridyl)-piperazin-1-yl!-propionyl!-amino!cyclohexane carboxylate, (e) Methyl 3-?4-trans-?4-(4-pyridyl)-piperazin-1-yl!-carbonylamino!cyclohexyl propionate, (f) Methyl ?4-trans-?4-(4-pyridyl)-piperazin-1-yl!-malonylamino!-cyclohexyl carboxylate, (g) Cyclohexyl ?4-trans-??4-(4-pyridyl)-piperazin-1-yl!-acetyl!-amino!-cyclohexane carboxylate, and (h) Isobutyl ?4-trans-??4-(4-pyridyl)-piperazin-1-yl!-acetyl!-amino!-cyclohexane carboxylate.